HYDERABAD: Pharmaceutical actor Hetero Labs has partnered with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) to manufacture more than 100 million doses of the Russian Covid-19 Sputnik V vaccine in India. The Sputnik V will be manufactured by Hetero’s biologics division, Hetero Biopharma, at Jadcherla in Hyderabad, with …
Read More »Coronavirus Vaccine: Hetero, RDIF Ink Pact to Produce 100 Million Doses of Russian Covid Sputnik V Vaccine in India | India Business News
